141 related articles for article (PubMed ID: 7684479)
1. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
[No Abstract] [Full Text] [Related]
2. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
[No Abstract] [Full Text] [Related]
3. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
[TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2010 Feb; 25(2):221-3. PubMed ID: 20136983
[No Abstract] [Full Text] [Related]
5. PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
Petit MA; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
J Hepatol; 1994 Jan; 20(1):47-56. PubMed ID: 8201222
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
J Hepatol; 1992 May; 15(1-2):202-6. PubMed ID: 1324270
[TBL] [Abstract][Full Text] [Related]
7. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
9. Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis.
Czaja AJ; Taswell HF; Rakela J; Schimek C
J Hepatol; 1992 Jan; 14(1):88-93. PubMed ID: 1310707
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
[TBL] [Abstract][Full Text] [Related]
12. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of hepatitis C virus antibody in diagnosis of hepatitis C].
Furuta S
Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):997-1000. PubMed ID: 2172428
[No Abstract] [Full Text] [Related]
14. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte alpha-A interferon.
Hess G; Gerlich W; Slusarczyk J; Hütteroth TH; Meyer zum Büschenfelde KH
J Hepatol; 1986; 3 Suppl 2():S245-51. PubMed ID: 3598157
[TBL] [Abstract][Full Text] [Related]
20. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan.
Nishioka K; Watanabe J; Furuta S; Tanaka E; Suzuki H; Iino S; Tsuji T; Yano M; Kuo G; Choo QL
Liver; 1991 Apr; 11(2):65-70. PubMed ID: 1646928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
